C. V. Chabata

Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass

B. Sullenger, S. Stayrook, R. Camire, 2018, Nature Biotechnology.

Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19.

B. Sullenger, L. Que, Ruwan Gunaratne, 2022, Nucleic acid therapeutics.

Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO

B. Sullenger, M. Kuchibhatla, D. Bonadonna, 2021, Molecular therapy. Nucleic acids.

Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation.

Nicolas L. Fawzi, J. Mittal, K. Burke, 2018, Molecular cell.

Emerging applications of aptamers for anticoagulation and hemostasis

B. Sullenger, Ruwan Gunaratne, C. V. Chabata, 2018, Current opinion in hematology.